1 Min Read
April 11 (Reuters) - Novo Nordisk A/S:
* NOVO NORDISK ANNOUNCES THE AVAILABILITY OF ZONOVATE FOR THE TREATMENT OF PATIENTS WITH HEMOPHILIA A IN QUEBEC Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.